13 | 0 | 2 |
下载次数 | 被引频次 | 阅读次数 |
目的 构建疼痛患者综合管理体系,并对其实施效果进行评价。方法 通过组建疼痛患者综合管理团队、采取医师-药师联合诊疗模式、建立疼痛患者综合管理档案以及提供以人文关怀为基石的患者教育,构建一套疼痛患者综合管理体系,为患者提供个体化用药服务。选取2023年3月至2024年2月期间就诊于疼痛门诊,实施医师-药师联合诊疗模式并建立完整档案的患者55例。利用数字分级评分法(NRS)评估患者疼痛强度变化,分析药物相关问题(DRPs)及开展镇痛药物氨酚羟考酮片的专项点评来评价疼痛患者综合管理体系的实施效果。结果 患者疼痛强度评分由干预前的(4.69±0.81)分下降到干预后的(3.24±0.69)分,差异具有高度统计学意义(P<0.01)。DRPs共发生49例次,其中用药依从性问题共33例次(占67.35%),药物安全性问题共11例次(占22.45%),DRPs解决率达91.84%。结论 医师-药师联合诊疗模式下的疼痛患者综合管理体系,有助于改善患者依从性,提高药物治疗有效性和安全性,进一步促进合理用药。
Abstract:AIM To develop a comprehensive management system for pain patients and evaluate its implementation effectiveness. METHODS The comprehensive management system for pain patients was established through multidisciplinary team formation, adoption of collaborative care model, creation of individualized management records, and humanistic patient education to deliver personalized medication services. A total of 55 patients who received physicianpharmacist collaborative care and had complete medical records in the pain clinic from March 2023 to February 2024 were enrolled. The implementation effect of the comprehensive management system for pain patients was evaluated by assessing pain intensity using the numerical rating scale(NRS), analyzing drug-related problems(DRPs), and conducting specialized reviews of oxycodone-acetaminophen tablet use. RESULTS The mean pain score decreased significantly from(4.69 ± 0.81) to(3.24 ± 0.69), indicating a statistically significant difference(P < 0.01). A total of 49 DRPs were identified, including 33(67.35%) adherence issues and 11(22.45%) safety concerns, with a resolution rate of 91.84%. CONCLUSION The comprehensive management system under the physician-pharmacist collaborative model improves patient adherence, enhances medication efficacy and safety, and promotes rational drug use.
[1]樊碧发.中国疼痛医学发展报告(2020)[M].北京:清华大学出版社, 2020:70-73.
[2]李惠钰.慢性疼痛,别忍![N].中国科学报, 2020-06-22(3).
[3]智晓旭,王守慧,鲍婷婷,等.居家癌痛患者镇痛治疗现状及影响因素分析[J].护理学杂志, 2014, 29(17):9.
[4]秦珺,郁件康,潘杰,等.苏州地区14家医疗机构患者药学门诊认知现状及药学需求调研[J].医药导报, 2023, 42(8):1165.
[5]黄蓉,田春艳,李茂兵,等.医师-药师联合癌痛门诊服务模式在门诊癌痛患者管理中的应用效果[J].中国临床药学杂志, 2023,32(6):408.
[6]梅隆,李飒,张宇晴,等.我国714家三级医疗机构药学门诊开展情况及影响因素分析[J].中国药房, 2024, 35(4):385.
[7] VEETTIL S K, DAROUICHE G, SAWANGJIT R, et al. Effects of pharmacist interventions on pain intensity:Systematic review and meta-analysis of randomized controlled trials[J]. J Am Pharm Assoc, 2022, 62(4):1313.
[8]谢菡,陆丽娟,马正良,等.疼痛药学门诊工作模式与成效[J].中国医院药学杂志, 2018, 38(12):1247.
[9]高培培,许晶晶,龚婧如,等.基于药物治疗管理的门诊癌痛患者全程化疼痛管理模式的效果评价[J].复旦学报(医学版), 2022,49(5):649.
[10] BALDO B A, ROSE M A. The anaesthetist, opioid analgesic drugs,and serotonin toxicity:a mechanistic and clinical review[J]. Br J Anaesth, 2020, 124(1):44.
[11]张珏.临床药师参与1例带状疱疹后神经痛治疗方案分析[J].药学研究, 2021, 40(3):203.
[12]王婧,郭澄,杨庆诚,等.基于疼痛药学服务构建骨肿瘤术后幻肢痛服务模式[J].中国药业, 2022, 31(17):19.
[13]宋春燕,王改利,吴红艳.慢性疼痛患者疼痛灾难化水平及影响因素分析[J].护理学杂志, 2024, 39(4):32.
[14]张培根,朱海丽,高卉.疼痛抑郁共病的研究进展[J].湖北科技学院学报(医学版), 2024, 38(3):270.
[15]黄金路,王婧,郭澄.医疗机构疼痛药物专项处方点评与干预体系的构建及探讨[J].中国临床药学杂志, 2020, 29(5):370.
[16]黄智然,苏夏雯,刁一凡,等.我国不同地区阿片类镇痛药物在癌痛治疗中的使用情况及个人经济负担[J].药物流行病学杂志, 2019,28(6):389.
基本信息:
DOI:10.19577/j.1007-4406.2025.06.006
中图分类号:R197.32
引用信息:
[1]黄彦珊,梁伟意,骆惠仪等.基于医师-药师联合诊疗模式构建疼痛患者综合管理体系及实施效果评价[J].中国临床药学杂志,2025,34(06):436-441.DOI:10.19577/j.1007-4406.2025.06.006.
基金信息:
江门市科技计划项目(编号2023YL03018)